Nöro Psikiyatri Arşivi,
Journal Year:
2022,
Volume and Issue:
unknown
Published: Jan. 1, 2022
Many
structural
and
functional
tests
are
used
to
explore
the
nature
of
neurodevelopmental
neurodegenerative
diseases.
Cognitive
involvement
has
become
more
remarkable
in
many
neurological
psychiatric
This
condition
evoked
a
paradigm
shift,
today
disorders
addressed
from
neuroscientific
perspective,
including
silent
symptoms.
The
spatial
resolution
studies
is
lacking
combined
with
unique
temporal
EEG
methods.
In
our
current
clinical
practice,
does
not
have
definitive
diagnostic
value
disorders,
but
it
helps
make
correct
diagnosis
by
excluding
other
However,
use
for
research
purposes
promising
both
groups.
this
review;
there
up-to-date
information
on
electrophysiological
examinations
diseases,
especially
Alzheimer's
disease,
Parkinson's
Frontotemporal
dementia,
such
as
schizophrenia,
mood
attention
deficit
hyperactivity
disorder,
obsessive-compulsive
define
point
we
reached
journey
understand
these
disorders.
Alzheimer s & Dementia,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 29, 2024
Many
coronavirus
disease
2019
(COVID-19)
positive
individuals
exhibit
abnormal
electroencephalographic
(EEG)
activity
reflecting
"brain
fog"
and
mild
cognitive
impairments
even
months
after
the
acute
phase
of
infection.
Resting-state
EEG
abnormalities
include
slowing
(reduced
alpha
rhythm;
increased
slow
waves)
epileptiform
activity.
An
expert
panel
conducted
a
systematic
review
to
present
compelling
evidence
that
deficits
due
COVID-19
Alzheimer's
related
dementia
(ADRD)
are
driven
by
overlapping
pathologies
neurophysiological
abnormalities.
seen
in
patients
resemble
those
observed
early
stages
neurodegenerative
diseases,
particularly
ADRD.
It
is
proposed
similar
Long
COVID
ADRD
parallel
neuroinflammation,
astrocyte
reactivity,
hypoxia,
neurovascular
injury.
These
underpinning
decline
can
be
detected
routine
exams.
Future
research
will
explore
value
monitoring
for
predicting
long-term
outcomes
efficacy
therapeutic
interventions.
HIGHLIGHTS:
Abnormal
intrinsic
electrophysiological
brain
activity,
such
as
EEG,
reduced
wave,
characteristic
findings
patients.
have
potential
neural
biomarkers
identify
neurological
complications
at
stage
disease,
assist
clinical
assessment,
assess
risk
Similar
typically
with
impairments,
Evidence
presented
supports
idea
resulting,
least
part,
from
neuroinflammatory
mechanisms
reactivity.
Identifying
common
biological
highlight
critical
underlying
disorders
decline.
elucidates
questions
regarding
impairment
not
yet
been
adequately
investigated.
Journal of Alzheimer s Disease,
Journal Year:
2022,
Volume and Issue:
88(3), P. 801 - 807
Published: June 24, 2022
The
National
Institute
of
Aging
and
Alzheimer's
Association
have
recently
proposed
a
framework
for
the
neurobiological
diagnosis
disease
(AD)
research
applications
[1].That
states
that
AD
can
be
based
on
biomarkers
derived
from
in
vivo
measurement
amyloidosis
('A'),
tauopathy
('T'),
neurodegeneration
('N')
brain
patients
with
AD,
regardless
clinical
manifestations
continuum
subjective
cognitive
complaint,
mild
impairment
(MCI),
mild,
moderate,
or
severe
degree
dementia
[1].Specifically,
measured
by
laboratory
analysis
cerebrospinal
fluid
positron
emission
tomography
(PET)
mapping,
while
probed
structural
magnetic
resonance
imaging
fluorodeoxyglucose
PET
European Archives of Psychiatry and Clinical Neuroscience,
Journal Year:
2023,
Volume and Issue:
274(4), P. 803 - 826
Published: Sept. 8, 2023
Transcranial
alternating
current
stimulation
(tACS)
is
a
non-invasive
brain
method
that,
through
its
manipulation
of
endogenous
oscillations,
can
affect
cognition
in
healthy
adults.
Given
the
fact
that
both
oscillations
and
are
impaired
various
psychiatric
diagnoses,
tACS
might
represent
suitable
intervention.
We
conducted
search
Pubmed
Web
Science
databases
reviewed
27
studies
where
used
diagnoses
change
evaluated.
TACS
safe
well-tolerated
intervention
method,
for
multiple-sessions
protocols.
It
be
administered
at
home,
individualized
according
to
patient''s
anatomical
functional
characteristics,
or
as
marker
disease
progression.
The
results
varying
across
applied
protocols,
with
some
protocols
showing
long-term
effect.
However,
overall
number
small
great
variety
parameters,
such
electrode
montage
frequency.
Precise
mechanisms
interaction
pathophysiological
processes
only
partially
described
need
further
research.
Currently,
seems
feasible
alleviate
cognitive
impairment
patients;
however,
more
robust
confirmation
efficacy
potential
needed
introduce
it
into
clinical
practise.
Brain Sciences,
Journal Year:
2024,
Volume and Issue:
14(6), P. 567 - 567
Published: June 3, 2024
Earlier
research
has
suggested
gender
differences
in
event-related
potentials/oscillations
(ERPs/EROs).
Yet,
the
alteration
oscillations
(EROs)
delta
and
theta
frequency
bands
have
not
been
explored
between
genders
across
three
age
groups
of
adulthood,
i.e.,
18–50,
51–65,
>65
years.
Data
from
155
healthy
elderly
participants
who
underwent
a
neurological
examination,
comprehensive
neuropsychological
assessment
(including
attention,
memory,
executive
function,
language,
visuospatial
skills),
magnetic
resonance
imaging
(MRI)
past
studies
were
used.
The
ERO
powers
compared
correlational
analyses
among
power,
age,
tests
performed.
results
indicated
that
females
displayed
higher
responses
than
males
frontal,
central,
parietal
regions
but
occipital
location
18
50
years
adulthood.
declining
power
EROs
women
reached
men
after
while
was
more
stable
men.
Our
imply
cohorts
must
be
recruited
at
specified
ranges
genders,
clinical
trials
using
neurophysiological
biomarkers
as
an
intervention
endpoint
should
take
into
account
future.